DOACs preferred over warfarin for most patients (lower intracranial haemorrhage risk, no routine monitoring)
Ablation vs antiarrhythmic drug therapy
CTI ablation > 90% single-procedure success for typical flutter
Antiarrhythmics offer 50-70% efficacy with ongoing drug side-effect burden
Ablation is preferred definitive therapy per 2015 ACC/AHA/HRS Guideline (Class I for recurrent)
Class IC agents (flecainide, propafenone) must not be used without concomitant AV nodal blocker
Risk of organizing AF into 1:1 flutter at rate 250-300 bpm (life-threatening)
Patient Discharge Instructions
copy discharge instructions
Discharge instructions for atrial flutter
Diagnosis and description
Your heart was beating in an abnormal rhythm called atrial flutter
Your heart was beating too fast (about 150 beats per minute)
Treatment was given to slow or restore your heart rate
Medications — take as prescribed
Rate control medication (beta-blocker or diltiazem): take every day even if feeling well
Blood thinner (anticoagulant): take every day to reduce stroke risk; do not miss doses
Do not stop any heart medication without talking to your doctor first
Activity and lifestyle
Avoid alcohol — it is a known trigger for atrial flutter
Limit or avoid caffeine if it triggers symptoms
Stay well hydrated
Resume light activity as tolerated; avoid strenuous exercise until cleared by cardiologist
Follow-up appointments
See your cardiologist or heart rhythm specialist (electrophysiologist) within 1-2 weeks
Discuss whether a heart procedure called ablation is right for you — it can cure flutter in over 90% of cases
Bring your medication list to every appointment
Bleeding precautions if on blood thinners
Use a soft-bristle toothbrush and electric razor
Avoid NSAIDs (ibuprofen, naproxen) unless approved by your doctor
Tell all doctors and dentists that you are on a blood thinner before any procedure
Return to the emergency department immediately for
Rapid heart racing, pounding, or fluttering in the chest
Fainting or near-fainting
Severe shortness of breath or chest pain
Facial drooping, arm weakness, speech difficulty, or sudden vision change (signs of stroke)
Coughing or vomiting blood, blood in urine or stools, or severe unusual bruising (signs of serious bleeding)
Feeling very dizzy or that your heart is pounding very fast
References
Guidelines and key sources
Primary guidelines
2015 ACC/AHA/HRS Guideline for Management of Adult Patients With Supraventricular Tachycardia — Page RL et al., JACC 2016 (Class I/IIa/IIb recommendations for flutter management and ablation)
2023 ACC/AHA/ACCP/HRS Guideline for Diagnosis and Management of Atrial Fibrillation — Joglar JA et al., JACC 2024 (anticoagulation and CHA2DS2-VASc strategy applied to flutter)
2019 AHA/ACC/HRS Focused Update of 2014 AF Guideline — January CT et al., Heart Rhythm 2019
2020 AHA Guidelines for CPR and Emergency Cardiovascular Care — Panchal AR et al., Circulation 2020 (cardioversion protocols)
2025 AHA Guidelines for Adult Advanced Life Support — Wigginton JG et al., Circulation 2025
Landmark texts and reviews
Link MS. Evaluation and Initial Treatment of Supraventricular Tachycardia. NEJM 2012
Hanna E. Atrial Flutter and Atrial Tachycardia. Practical Cardiovascular Medicine 2e. 2022
Peng G, Zei PC. Diagnosis and Management of Paroxysmal SVT. JAMA 2024
Blomstrom-Lundqvist C et al. ACC/AHA/ESC Guidelines for Management of SVT — Executive Summary. JACC 2003
ECG and electrophysiology references
Bayes De Luna A et al. Diagnosis of Arrhythmias in Clinical Practice. Clinical Electrocardiography 2021
Bayes De Luna A et al. Active Supraventricular Arrhythmias. Clinical Electrocardiography 2021
Hanna E. Approach to Narrow and Wide QRS Complex Tachyarrhythmias. Practical Cardiovascular Medicine 2e. 2022
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.